Reliant AI Announces
$11.3M Seed Round

We are happy to announce the closing of our Seed financing round, co-led by iNovia Ventures and Tola Capital, with participation by Mike Volpi.

Our Team

We're bringing the future of AI to pharma.

At Reliant AI, we believe that the transformative impact of generative AI will be only realized by those willing to take on the world’s biggest information challenges. To make this future come true, we deploy our longstanding expertise in reinforcement learning and natural language processing to some of the hardest problems in pharma, the life sciences and beyond.

Our mission is impact.

We are a global team, driven by a shared mission: leveraging the power of AI to improve the ability of others to excel at their work. Our team of world-leading AI researchers, software engineers and life sciences experts is pushing the state of the art in ML & AI in pursuit of this goal every day.

Our Founding Team

We are scientists. Builders. Entrepreneurs. We spearheaded many of AI’s most impactful applications. We led teams at Google, DeepMind, and EY Parthenon. We are now bridge cutting-edge AI research and the biopharma industry.

Locations

Montreal
Berlin
Denver

Supported by

In this ProFIT project we develop a system to simplify knowledge work through the help of AI. AI is used as a tool for enterprise illumination rather than automation, so as to do justice to the analytical requirements of advanced tasks. The main focus of this project is to research algorithms and language models that prioritise precision over speed and that prioritise recall as an overall metric so as to satisfy the requirements for use in a genuine knowledge work context.

Project: Wissensarbeit mit generativer KI
Application Number: 10207304

Join our team.

We are only getting started. Join us at Reliant AI and be part of a team that is bringing the power of AI to where it matters most.